Distinct renal adverse event profiles among CDK4/6 inhibitors: a comparative pharmacovigilance analysis
Objective Renal adverse events associated with cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have gained increasing attention in clinical practice. However, comparative real-world data regarding renal safety profiles among individual CDK4/6 inhibitors remain limited. This study aimed to characterize renal adverse...